Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Bioscience.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alligator, Eusa, Horizon, Inflarx, Inmed, Lidds, Novo Nordisk, Oncoceutics, Orchard, Ose, Theranexus.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Altasciences, Cytodyn, Eagle, Healios, Immutep, Medimetriks, Opthea, Otsuka, Partner, Pluristem, Qurient, Regeneron, Revive, Roivant Sciences, Sanofi, Symbio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Edwards, Grail, Pixium Vision.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Bausch, Biocardia, Biomx, Chimed, Dicerna, Eyegate, Genfit, GT Biopharma, Iterum, Kiniksa, Matinas, Mersana, Mimetogen, Orphomed, Proqr, Reata, Synairgen, Verona, Xenon.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Medtronic.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Aveo, Axsome, Biohaven, Cabaletta, Can-Fite, Cohbar, Cytodyn, Eagle, Faron, Immunovant, Inovio, Intensity, Mediwound, Opthea, Ovid, Oyster, Phasebio, Polyphor, Pluristem, Regeneron, Resverlogix, Revive, Sanofi, Symbio, Synlogic, Seres, Tcr2, Zealand.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Altasciences, Arbutus, Translate Bio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: BMS, Bolt, Decibel, Healios, Imcheck, Inovio, Ipsen, Ironwood, Medimetriks, Oncopeptides, Otsuka, Qurient, Tolero, Uniqure, VBL.